Annual Shareholders Equity
$1.15 B
-$80.96 M-6.56%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual stockholders equity is $1.15 billion, with the most recent change of -$80.96 million (-6.56%) on December 31, 2023.
- During the last 3 years, ABCL annual shareholders equity has risen by +$321.81 million (+38.75%).
- ABCL annual shareholders equity is now -6.56% below its all-time high of $1.23 billion, reached on December 31, 2022.
Performance
ABCL Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.08 B
-$32.87 M-2.96%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly stockholders equity is $1.08 billion, with the most recent change of -$32.87 million (-2.96%) on September 30, 2024.
- Over the past year, ABCL quarterly shareholders equity has dropped by -$32.87 million (-2.96%).
- ABCL quarterly shareholders equity is now -13.76% below its all-time high of $1.25 billion, reached on September 30, 2022.
Performance
ABCL Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
ABCL Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.6% | -3.0% |
| 3 y3 years | +38.8% | +13.1% |
| 5 y5 years | +9825.9% | +10000.0% |
ABCL Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.6% | +12.3% | -13.8% | +5.1% |
| 5 y | 5-year | -6.6% | >+9999.0% | -13.8% | >+9999.0% |
| alltime | all time | -6.6% | >+9999.0% | -13.8% | >+9999.0% |
AbCellera Biologics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.08 B(-3.0%) |
| Jun 2024 | - | $1.11 B(-1.7%) |
| Mar 2024 | - | $1.13 B(-1.9%) |
| Dec 2023 | $1.15 B(-6.6%) | $1.15 B(-2.6%) |
| Sep 2023 | - | $1.18 B(-1.0%) |
| Jun 2023 | - | $1.19 B(-1.1%) |
| Mar 2023 | - | $1.21 B(-2.0%) |
| Dec 2022 | $1.23 B | $1.23 B(-1.4%) |
| Sep 2022 | - | $1.25 B(+3.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $1.21 B(+0.4%) |
| Mar 2022 | - | $1.21 B(+17.7%) |
| Dec 2021 | $1.03 B(+23.5%) | $1.03 B(+7.6%) |
| Sep 2021 | - | $953.40 M(-1.5%) |
| Jun 2021 | - | $967.68 M(+1.1%) |
| Mar 2021 | - | $957.12 M(+15.2%) |
| Dec 2020 | $830.51 M(+8000.9%) | $830.51 M(+830.7%) |
| Sep 2020 | - | $89.24 M(+770.4%) |
| Dec 2019 | $10.25 M(-11.7%) | $10.25 M |
| Dec 2018 | $11.61 M | - |
FAQ
- What is AbCellera Biologics annual stockholders equity?
- What is the all time high annual shareholders equity for AbCellera Biologics?
- What is AbCellera Biologics annual shareholders equity year-on-year change?
- What is AbCellera Biologics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AbCellera Biologics?
- What is AbCellera Biologics quarterly shareholders equity year-on-year change?
What is AbCellera Biologics annual stockholders equity?
The current annual shareholders equity of ABCL is $1.15 B
What is the all time high annual shareholders equity for AbCellera Biologics?
AbCellera Biologics all-time high annual stockholders equity is $1.23 B
What is AbCellera Biologics annual shareholders equity year-on-year change?
Over the past year, ABCL annual stockholders equity has changed by -$80.96 M (-6.56%)
What is AbCellera Biologics quarterly stockholders equity?
The current quarterly shareholders equity of ABCL is $1.08 B
What is the all time high quarterly shareholders equity for AbCellera Biologics?
AbCellera Biologics all-time high quarterly stockholders equity is $1.25 B
What is AbCellera Biologics quarterly shareholders equity year-on-year change?
Over the past year, ABCL quarterly stockholders equity has changed by -$32.87 M (-2.96%)